(Allergan plc)

	AGN latest price $238.3279 (-0.96%) ($236.6775 - $240.8084) on Thu. Feb. 16, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.48% (three month average)
RSI	89
Latest Price	$238.3279(-0.96%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 5.8% a week on average for past two weeks.
Market Behavior	Normal for large cap. Growth stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    SPY(44%)    XBI(44%)    ARKG(43%)
Factors Impacting AGN price	AGN will decline at least -0.74% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-14%)    SHY(-3%)    IPO(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.74% (StdDev 1.48%)
Hourly BBV	0 ()
Intraday Trend	-1%

5 Day Moving Average	$238.96(-0.26%)
10 Day Moving Average	$234.2(1.76%)
20 Day Moving Average	$222.45(7.14%)
To recent high	-1%
To recent low	31%
Market Cap	$78.577b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed